COCP

0.95002.05%
JJ

James J. Martin

CFO & Corporate Secretary

Mr. James J. Martin, C.P.A., M.B.A., also known as Jim, is Director of Non-Invasive Monitoring Systems, Inc. since June 01, 2023. He served as Co-Chief Executive Officer at Cocrystal Pharma, Inc. since May 2023 until June 03, 2026 and had been its Interim Co-Chief Executive Officer since May 26, 2021 until May 2023 and is its Chief Financial Officer since June 1, 2017 and served as its Interim Chief Financial Officer from February 23, 2017 to June 1, 2017. Mr. Martin served as a Director of Big Cypress Acquisition Corp. from November 2020 to December 22, 2021. Since November 2016, Mr. Martin serves as Corporate Secretary of Cocrystal Pharma, Inc. Additionally, from 2016 to 2017, Mr. Martin served as Chief Financial Officer of Motus GI Holdings, Incorporated (Nasdaq: MOTS) a medical device company based in Haifa, Israel. He serves as Chief Financial Officer of Non-Invasive Monitoring Systems, Inc. since January 2011 and serves as its Treasurer. Mr. Martin served as the Chief Financial Officer of MOTUS GI Medical Technologies Ltd. from November 28, 2016 to June 28, 2017. He served as the Chief Financial Officer of VBI Vaccines, Inc. from September 2014 to September 1, 2016. Mr. Martin served as the Chief Financial Officer of SciVac Therapeutics Inc. from 2014 to 2017. Mr. Martin served as Acting Chief Financial Officer at Non-Invasive Monitoring Systems Inc since January 10, 2011. Mr. Martin also served as a director of SAB Biotherapeutics, Incorporated from November 2020 to October 22, 2021. He served as the Chief Financial Officer of Vapor Corp. from April 2014 to September 10, 2015. He served as the Chief Financial Officer of Vaporin, Inc. since April 22, 2014. From 2005 to 2008, Mr. Martin served as the Controller of Avborne Heavy Maintenance, Inc. Mr. Martin served as Chief Financial Officer of Avborne Heavy Maintenance, Inc., a venture capital owned aviation company from 2006 to 2011. During his tenure, Mr. Martin was played an integral role in the sale of Avborne Heavy Maintenance to AAR Corporation (NYSE: AIR) in 2008. He served as Controller at Non-Invasive Monitoring Systems Inc. from July 2010 to January 2011. He served as Acting Chief Financial Officer of SafeStitch Medical, Inc. from July 2010 to January 19, 2011. Mr. Martin served as the Chief Financial Officer of SafeStitch Medical, Inc. (now TransEnterix, Inc.) from January 10, 2011 to October 2, 2013 and served as its Principal Accounting Officer. From January 2011 to December 2011, he also served as Vice President of Finance of Aero Pharmaceuticals, Inc. and Controller from July 2010 to January 2011. He served as President of AAR Aircraft Services- Miami, Inc. and served as its Chief Financial Officer since 2001. From 2008 through 2010, Mr. Martin served as Controller of AAR Aircraft Services-Miami. He served as a Director of VBI Vaccines, Inc since July 09, 2015. In his career in finance and accounting, Mr. Martin served in the United States Navy as an Operations Specialist from 1985 to 1990. He is a Certified Public Accountant. Mr. Martin holds an undergraduate degree in business administration and an MBA from Barry University. He also received his MBA from Emory University and completed his graduate work in accounting at Florida International University.

Positions